A leading role for the immune system in the pathophysiology of preeclampsia

Journal of Leukocyte Biology

Volumn 94, Issue 2, 2013, Pages 247-257

  Laresgoiti Servitje, Estibalitz ^a,b  

^a AMERICAN BRITISH COWDRAY MEDICAL CENTER   (Mexico)

^b UNIVERSIDAD PANAMERICANA   (Mexico)

Author keywords

B cell; Dendritic cell; Lymphocyte; Monocyte; Neutrophil; Preeclampsia; STBM; TLR

Indexed keywords

ADRENERGIC RECEPTOR; ANGIOGENIC FACTOR; ANGIOTENSIN 1 RECEPTOR; AUTOANTIBODY; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; CELL ACTIVATION; CELL ACTIVITY; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; HYPOXIA; IMMUNE SYSTEM; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; MEMBRANE MICROPARTICLE; MOLECULE; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BINDING; REGULATORY T LYMPHOCYTE; REVIEW; SYNCYTIOTROPHOBLAST; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL;

B CELL; DENDRITIC CELL; LYMPHOCYTE; MONOCYTE; NEUTROPHIL; PREECLAMPSIA; STBM; TLR;

ADAPTIVE IMMUNITY; ANGIOGENIC PROTEINS; AUTOANTIBODIES; CELL HYPOXIA; CELL-DERIVED MICROPARTICLES; CYTOKINES; DENDRITIC CELLS; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION; IMMUNITY, INNATE; INFLAMMATION; LEUKOCYTES; MICRORNAS; NEUTROPHIL ACTIVATION; NF-KAPPA B; OXIDATIVE STRESS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ADRENERGIC; T-LYMPHOCYTE SUBSETS; TROPHOBLASTS;

EID: 84880990123     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1112603     Document Type: Review

References (149)

1. Davey, D., Macgillivray, I., James, M. R., Richard, J. L. (1989) Classification of hypertensive disorders in pregnancy. Lancet 334, 112-113.
2. Chappell, L. C, Enye, S., Seed, P., Briley, A. L., Poston, L., Shennan, A. H. (2008) Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension 51, 1002-1009.
3. James, J. L., Stone, P. R, Chamley, L. W. (2005) Cytotrophoblast differentiation in the first trimester of pregnancy: evidence for separate progenitors of extravillous trophoblasts and syncytiotrophoblast. Reproduction 130, 95-103.
4. Roberts, J. M., Gammill, H. S. (2005) Preeclampsia: recent insights. Hypertension 46, 1243-1249.
5. Kaufmann, P., Black, S., Huppertz, B. (2003) Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol. Reprod. 69, 1-7.
6. Odegard, R A, Vatten, L. J., Nilsen, S. T., Salvesen, K. A, Austgulen, R (2000) Preeclampsia and fetal growth. Obstet. Gynecol. 96, 950-955.
7. Rolfo, A, Many, A., Racano, A, Tal, R, Tagliaferro, A, Ietta, F., Wang, J., Post, M., Caniggia, I. (2010) Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies. PLoS ONE 5, e13288.
8. Laresgoiti-Servitje, E., Gómez-López, N., Olson, D. M. (2010) An immunological insight into the origins of pre-eclampsia. Hum. Reprod. Update 16, 510-524.
9. Mellembakken, J. R, Aukrust, P., Hestdal, K, Ueland, T., Abyholm, T., Videm, V. (2001) Chemokines and leukocyte activation in the fetal circulation during preeclampsia. Hypertension 38, 394-398.
10. Sargent, I. L., Borzychowski, A. M., Redman, C. W. G. (2006) Immuno-regulation in normal pregnancy and pre-eclampsia: an overview. Rep. BioMed. Online 13, 680-686.
11. Srinivas, S. K, Edlow, A. G., Neff, P. M., Sammel, M. D., Andrela, C. M., Elovitz, M. A. (2009) Rethinking IUGR in preeclampsia: dependent or independent of maternal hypertension? J. Perinatol. 29, 680-684.
12. Van der Merwe, J. L., Hall, D. R, Wright, C, Schubert, P., Grové, D. (2010) Are early and late preeclampsia distinct subclasses of the disease-what does the placenta reveal? Hypertens. Pregnancy 29, 457-467.
13. Parrish, M. R, Murphy, S. R., Rutland, S., Wallace, K, Wenzel, K, Wal-lukat, G., Keiser, S., Ray, L. F., Dechend, R, Martin, J. N., Granger, J. P., LaMarca, B. (2010) The effect of immune factors, tumor necrosis factor-a, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy. Am. J. Hypertens. 23, 911-916.
14. Parrish, M. R, Wallace, K, Tam Tam, K. B., Herse, F., Weimer, A, Wenzel, K, Wallukat, G., Ray, L. F., Arany, M., Cockrell, K, Martin, J. N., Dechend, R, LaMarca, B. (2011) Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension. Am. J. Hypertens. 24, 835-840.
15. Sela, S., Itin, A, Natanson-Yaron, S., Greenfield, C, Goldman-Wohl, D., Yagel, S., Keshet, E. (2008) A novel human-specific soluble vascular endothelial growth factor receptor 1: cell type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia. Circ. Res. 102, 1566-1574.
16. Noack, F., Ribbat-Idel, J., Thorns, C, Chiriac, A, Axt-Fliedner, R, Diedrich, K, Feller, A. C. (2011) miRNA expression profiling in formalin-fixed and paraffin-embedded placental tissue samples from pregnancies with severe preeclampsia. J. Perinat. Med. 39, 267-271.
17. Zhang, Z., Sun, H., Dai, H., Walsh, R., Imakura, M., Schelter, J., Bur-chard, J., Dai, X., Chang, A. N., Diaz, R L., Marszalek, J. R, Bartz, S. R, Carleton, M., Cleary, M. A, Linsley, P. S., Grandori, C. (2009) MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle 8, 2756-2768.
18. Nevo, O., Soleymanlou, N., Wu, Y, Xu, J., Kingdom, J., Many, A., Za-mudio, S., Caniggia, I. (2006) Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am. J. Physiol. 291, R1085-R1093.
19. Levine, R. J., Lam, C, Qian, C, Yu, K. F., Maynard, S. E., Sachs, B. P., Sibai, B. M., Epstein, F. H., Romero, R, Thadhani, R., Karumanchi, S. A, CPEP Study Group (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N. Engl. J. Med. 355, 992-1005.
20. Gould, P. S., Gu, M., Liao, J., Ahmad, S., Cudmore, M. J., Ahmed, A, Vatish, M. (2010) Upregulation of urotensin II receptor in preeclampsia causes in vitro placental release of soluble vascular endothelial growth factor receptor 1 in hypoxia. Hypertension 56, 172-178.
21. Sela, S., Natanson-Yaron, S., Zcharia, E., Vlodavsky, I., Yagel, S., Keshet, E. (2011) Local retention versus systemic release of soluble VEGF receptor-1 are mediated by heparin-binding and regulated by hepara-nase. Circ. Res. 108, 1063-1070.
22. Maynard, S. E., Min, J-Y, Merchan, J., Lim, K-H., Li, J., Mondal, S., Libermann, T. A, Morgan, J. P., Sellke, F. W., Stillman, I. E., Epstein, F. H., Sukhatme, V. P., Karumanchi, S. A. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111, 649-658.
23. Wang, A, Rana, S., Karumanchi, S. A. (2009) Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology 24, 147-158.
24. Gu, Y, Lewis, D. F., Wang, Y (2008) Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies. J. Clin. Endocrinol. Metab. 93, 260-266.
25. Fujita, D., Tanabe, A, Sekijima, T., Soen, H., Narahara, K, Yamashita, Y, Terai, Y, Kamegai, H., Ohmichi, M. (2010) Role of extracellular signal-regulated kinase and AKT cascades in regulating hypoxia-in-duced angiogenic factors produced by a trophoblast-derived cell line. J. Endocrinol. 206, 131-140.
26. Jung, J-J., Tiwari, A, Inamdar, S. M., Thomas, C. P., Goel, A, Choud-hury, A. (2012) Secretion of soluble vascular endothelial growth factor receptor 1 (sVEGFR1/sFlt1) requires Arf1, Arf6, and Rab11 GTPases. PLoS ONE 7, e44572.
27. Munaut, C, Lorquet, S., Pequeux, C, Blacher, S., Berndt, S., Fran-kenne, F., Foidart, J-M. (2008) Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast. Hum. Reprod. 23, 1407-1415.
28. Thomas, C. P., Andrews, J. I., Raikwar, N. S., Kelley, E. A, Herse, F., Dechend, R, Golos, T. G., Liu, K. Z. (2009) A recently evolved novel trophoblast-enriched secreted form of fms-Like tyrosine kinase-1 variant is up-regulated in hypoxia and preeclampsia. J. Clin. Endocrinol. Metab. 94, 2524-2530.
29. Levine, R J., Maynard, S. E., Qian, C, Lim, K-H., England, L. J., Yu, K F., Schisterman, E. F., Thadhani, R, Sachs, B. P., Epstein, F. H., Sibai, B. M., Sukhatme, V. P., Karumanchi, S. A. (2004) Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350, 672-683.
30. Herse, F., Verlohren, S., Wenzel, K, Pape, J., Muller, D. N., Modrow, S., Wallukat, G., Luft, F. C, Redman, C. W. G., Dechend, R (2009) Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. Hypertension 53, 393-398.
31. Murphy, S. R, Lamarca, B. B., Parrish, M., Cockrell, K, Granger, J. P. (2013) Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-a. Am. J. Physiol. 304, R130-R135.
32. Zhou, C. C, Ahmad, S., Mi, T., Abbasi, S., Xia, L., Day, M-C, Ramin, S. M., Ahmed, A, Kellems, R E., Xia, Y (2008) Autoantibody from women with preeclampsia induces soluble Fms-Like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension 51, 1010-1019.
33. Irani, R A, Zhang, Y, Zhou, C. C, Blackwell, S. C, Hicks, M. J., Ramin, S. M., Kellems, R E., Xia, Y (2010) Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-a signaling. Hypertension 55, 1246-1253.
34. Gilad, S., Meiri, E., Yogev, Y, Benjamin, S., Lebanony, D., Yerushalmi, N., Benjamin, H., Kushnir, M., Cholakh, H., Melamed, N., Bentwich, Z., Hod, M., Goren, Y, Chajut, A. (2008) Serum microRNAs are promising novel biomarkers. PLoS ONE 3, e3148.
35. Hu, Y, Li, P., Hao, S., Liu, L., Zhao, J., Hou, Y (2009) Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia. Clin. Chem. Lab. Med. 47, 923-929.
36. Pineles, B. L., Romero, R, Montenegro, D., Tarca, A. L., Han, Y M., Kim, Y M., Draghici, S., Espinoza, J., Kusanovic, J. P., Mittal, P., Hassan, S. S., Kim, C.J. (2007) Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am. J. Obstet. Gynecol. 196, 261 e261-e266.
37. O'Neill, L. A. J. (2010) Outfoxing Foxo1 with miR-182. Nat. Immunol. 11, 983-984.
38. Tang, T., Wong, H. K., Gu, W., Yu, M. Y, To, K. F., Wang, C. C, Wong, Y F., Cheung, T. H., Chung, T. K, Choy, K. W. (2013) MicroRNA-182 plays an onco-miRNA role in cervical cancer. Gynecol. Oncol. 129, 199-208.
39. Zhang, Y, Fei, M., Xue, G., Zhou, Q., Jia, Y, Li, L., Xin, H., Sun, S. (2012) Elevated levels of hypoxia-inducible microRNA-210 in pre-ec-lampsia: new insights into molecular mechanisms for the disease. J. Cell. Mol. Med. 16, 249-259.
40. Zhang, Y, Diao, Z., Su, L., Sun, H., Li, R, Cui, H., Hu, Y (2010) MicroRNA-155 contributes to preeclampsia by down-regulating CYR61. Am. J. Obstet. Gynecol. 202, 466.e1-466.e7.
41. Messerli, M., May, K, Hansson, S. R, Schneider, H., Holzgreve, W., Hahn, S., Rusterholz, C. (2010) Feto-maternal interactions in pregnancies: placental microparticles activate peripheral blood monocytes. Pla-centa 31, 106-112.
42. Germain, S. J., Sacks, G. P., Soorana, S. R., Sargent, I. L., Redman, C.W. (2007) Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J. Immunol. 178, 5949-5956.
43. Southcombe, J., Tannetta, D., Redman, C., Sargent, I. (2011) The im-munomodulatory role of syncytiotrophoblast microvesicles. PLoS ONE 6, e20245.
44. Guller, S., Tang, Z., Ma, Y. Y., Di Santo, S., Sager, R., Schneider, H. (2011) Protein composition of microparticles shed from human pla centa during placental perfusion: potential role in angiogenesis and fibrinolysis in preeclampsia. Placenta 32, 63-69.
45. Lee, S. M., Romero, R., Lee, Y. J., Park, I. S., Park, C-W., Yoon, B. H. (2012) Systemic inflammatory stimulation by microparticles derived from hypoxic trophoblast as a model for inflammatory response in pre-eclampsia. Am. J. Obstet. Gynecol. 207, 337.e1-337.e8.
46. Holder, B. S., Tower, C. L., Jones, C. J. P., Aplin, J. D., Abrahams, V. M. (2012) Heightened pro-inflammatory effect of preeclamptic pla-cental microvesicles on peripheral blood immune cells in humans. Biol. Reprod. 86, 103, 101-107.
47. Von Dadelszen, P., Hurst, G., Redman, C. W. G. (1999) Supernatants from co-cultured endothelial cells and syncytiotrophoblast microvillous membranes activate peripheral blood leukocytes in vitro. Hum. Reprod. 14, 919-924.
48. Matzinger, P. (2002) The danger model: a renewed sense of self. Science 296, 301-305.
49. Bonney, E. A. (2007) Preeclampsia: a view through the danger model. J. Reprod. Immunol. 76, 68-74.
50. Lotze, M. T., Deisseroth, A., Rubartelli, A. (2007) Damage associated molecular pattern molecules. Clin. Immunol. 124, 1-4.
51. Yang, H., Wang, H., Czura, C. J., Tracey, K. J. (2005) The cytokine activity of HMGB1. J. Leukoc. Biol. 78, 1-8.
52. Schmidt, A. P., Tort, A. B. L., Amaral, O. B., Schmidt, A. P., Walz, R., Vettorazzi-Stuckzynski, J., Martins-Costa, S. H., Ramos, J. G. L., Souza, D.O., Portela, L. V. C. (2004) Serum S100B in pregnancy-related hy pertensive disorders: a case-control study. Clin. Chem. 50, 435-438.
53. Holmlund, U., Wähämaa, H., Bachmayer, N., Bremme, K., Sverremark-Ekström, E., Palmblad, K. (2007) The novel inflammatory cytokine high mobility group box protein 1 (HMGB1) is expressed by human term placenta. Immunology 122, 430-437.
54. Tskitishvili, E., Komoto, Y., Temma-Asano, K., Hayashi, S., Kinugasa, Y., Tsubouchi, H., Song, M., Kanagawa, T., Shimoya, K., Murata, Y. (2006) S100B protein expression in the amnion and amniotic fluid in pregnancies complicated by pre-eclampsia. Mol. Hum. Reprod. 12, 755-761.
55. Tskitishvili, E., Sharentuya, N., Temma-Asano, K., Mimura, K., Kinu-gasa-Taniguchi, Y., Kanagawa, T., Fukuda, H., Kimura, T., Tomimatsu, T., Shimoya, K. (2010) Oxidative stress-induced S100B protein from placenta and amnion affects soluble endoglin release from endothelial cells. Mol. Hum. Reprod. 16, 188-199.
56. Kim, Y. M., Romero, R., Oh, S. Y., Kim, C. J., Kilburn, B. A., Armant, D. R., Nien, J. K., Gomez, R., Mazor, M., Saito, S., Abrahams, V. M., Mor, G. (2005) Toll-like receptor 4: a potential link between "danger signals," the innate immune system, and preeclampsia? Am. J. Obstet. Gynecol. 193, 921-927.
57. Pineda, A., Verdin-Teran, S. L., Camacho, A., Moreno-Fierros, L. (2011) Expression of Toll-like receptor TLR-2, TLR-3, TLR-4 and TLR-9 is increased in placentas from patients with preeclampsia. Arch. Med. Res. 42, 382-391.
58. Chatterjee, P., Chiasson, V. L., Kopriva, S. E., Young, K. J., Chatterjee, V., Jones, K. A., Mitchell, B. M. (2011) Interleukin 10 deficiency exacerbates Toll-like receptor 3-induced preeclampsia-like symptoms in mice. Hypertension 58, 489-496.
59. Hennessy, A., Pilmore, H. L., Simmons, L. A., Painter, D. M. (1999) A deficiency of placental IL-10 in preeclampsia. J. Immunol. 163, 3491-3495.
60. Chatterjee, P., Weaver, L. E., Doersch, K. M., Kopriva, S. E., Chiasson, V. L., Allen, S. J., Narayanan, A. M., Young, K. J., Jones, K. A., Kuehl, T. J., Mitchell, B. M. (2012) Placental Toll-like receptor 3 and Toll-like receptor 7/8 activation contributes to preeclampsia in humans and mice. PLoS ONE 7, e41884-e41884.
61. Scharfe-Nugent, A., Corr, S. C., Carpenter, S. B., Keogh, L., Doyle, B., Martin, C., Fitzgerald, K. A., Daly, S., O'Leary, J. J., O'Neill, L. A. J. (2012) TLR9 provokes inflammation in response to fetal DNA: mecha nism for fetal loss in preterm birth and preeclampsia. J. Immunol. 188, 5706-5712.
62. Leung, T. N., Zhang, J., Lau, T. K., Chan, L. Y. S., Lo, Y. M. D. (2001) Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin. Chem. 47, 137-139.
63. Conde-Agudelo, A., Villar, J., Lindheimer, M. (2008) Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am. J. Obstet. Gynecol. 198, 7-22.
64. Kawai, T., Akira, S. (2009) The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 21, 317-337.
65. Vásárhelyi, B., Cseh, A., Kocsis, I., Treszl, A., Györffy, B., Rigó Jr., J. (2006) Three mechanisms in the pathogenesis of pre-eclampsia suggested by over-represented transcription factor-binding sites detected with comparative promoter analysis. Mol. Hum. Reprod. 12, 31-34.
66. Li, Q., Verma, I. M. (2002) NF-kB regulation in the immune system. Nat. Rev. Immunol. 2, 725-734.
67. Luppi, P., Tse, H., Lain, K. Y., Markovic, N., Piganelli, J. D., DeLoia, J. A. (2006) Preeclampsia activates circulating immune cells with engagement of the NF-kB pathway. Am. J. Reprod. Immunol. 56, 135-144.
68. Vaughan, J. E., Walsh, S. W. (2012) Activation of NF-kB in placentas of women with preeclampsia. Hypertens. Pregnancy 31, 243-251.
69. Kawai, T., Akira, S. (2007) Signaling to NF-kB by Toll-like receptors. Trends Mol. Med. 13, 460-469.
70. Sykes, L., MacIntyre, D. A, Yap, X. J., Ponnampalam, S., Teoh, T. G., Bennett, P. R. (2012) Changes in the Th1: Th2 cytokine bias in pregnancy and the effects of the anti-inflammatory cyclopentenone prostaglandin 15-deoxy-A(12,14)-prostaglandin J2. Mediators Inflamm. 2012, 416739.
71. Gomez-Lopez, N., Guilbert, L. J., Olson, D. M. (2010) Invasion of the leukocytes into the fetal-maternal interface during pregnancy. J. Leukoc. Biol. 88, 625-633.
72. Abrahams, V. M., Visintin, I., Aldo, P. B., Guller, S., Romero, R, Mor, G. (2005) A role for TLRs in the regulation of immune cell migration by first trimester trophoblast cells.J. Immunol. 175, 8096-8104.
73. Bowen, R S., Gu, Y, Zhang, Y, Lewis, D. F., Wang, Y (2005) Hypoxia promotes interleukin-6 and-8 but reduces interleukin-10 production by placental trophoblast cells from preeclamptic pregnancies. J. Soc. Gynecol. Investig. 12, 428-432.
74. Benyo, D. F., Smarason, A., Redman, C. W. G., Sims, C, Conrad, K. P. (2001) Expression of inflammatory cytokines in placentas from women with preeclampsia. J. Clin. Endocrinol. Metab. 86, 2505-2512.
75. Luppi, P., DeLoia, J. A. (2006) Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clin. Immunol. 118, 268-275.
76. Ziegler-Heitbrock, L., Ancuta, P., Crowe, S., Dalod, M., Grau, V., Hart, D. N., Leenen, P. J. M., Liu, Y-J., MacPherson, G., Randolph, G. J., Scherberich, J., Schmitz, J., Shortman, K, Sozzani, S., Strobl, H., Zem-bala, M., Austyn, J. M., Lutz, M. B. (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116, e74-e80.
77. Melgert, B. N., Spaans, F., Borghuis, T., Klok, P. A, Groen, B., Bolt, A, de Vos, P., van Pampus, M. G., Wong, T. Y, van Goor, H., Bakker, W. W., Faas, M. M. (2012) Pregnancy and preeclampsia affect monocyte subsets in humans and rats. PLoS ONE 7, e45229.
78. Al-Ofi, E., Coffelt, S. B., Anumba, D. O. (2012) Monocyte subpopula-tions from pre-eclamptic patients are abnormally skewed and exhibit exaggerated responses to Toll-like receptor ligands. PLoS ONE 7, e42217.
79. Zawada, A. M., Rogacev, K. S., Rotter, B., Winter, P., Marell, R-R, Fliser, D., Heine, G. H. (2011) SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood 118, e50-e61.
80. Ancuta, P., Weiss, L., Haeffner-Cavaillon, N. (2000) CD14 + CD16+ + cells derived in vitro from peripheral blood monocytes exhibit pheno-typic and functional dendritic cell-like characteristics. Eur. J. Immunol. 30, 1872-1883.
81. Khalil, R A, Granger, J. P. (2002) Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am. J. Physiol. 283, R29-R45.
82. Vila, E., Salaices, M. (2005) Cytokines and vascular reactivity in resistance arteries. Am. J. Physiol. Heart Circ. Physiol. 288, H1016-H1021.
83. Greer, I., Haddad, N., Dawes, J., Johnstone, F., Calder, A. (1989) Neutrophil activation in pregnancy-induced hypertension. Br. J. Obstet. Gynaecol. 96, 978-982.
84. Greer, I., Dawes, J., Johnston, T., Calder, A. (1991) Neutrophil activation is confined to the maternal circulation in pregnancy-induced hypertension. Obstet. Gynecol. 78, 28-32.
85. Butterworth, B., Greer, I., Liston, W., Haddad, N., Johnston, T. (1991) Immunocytochemical localization of neutrophil elastase in term placenta decidua and myometrium in pregnancy-induced hypertension. Br. J. Obstet. Gynaecol. 98, 929-933.
86. Cadden, K, Walsh, S. (2008) Neutrophils, but not lymphocytes or monocytes, infiltrate maternal systemic vasculature in women with preeclampsia. Hypertens. Pregnancy 27, 396-405.
87. Tsukimori, K, Tsushima, A, Fukushima, K, Nakano, H., Wake, N. (2008) Neutrophil-derived reactive oxygen species can modulate neutrophil adhesion to endothelial cells in preeclampsia. Am. J. Hypertens. 21, 587-591.
88. Quinn, M., Linner, J., Siemsen, D., Dratz, E., Buescher, E., Jesaitis, A. (1995) Immunocytochemical detection of lipid peroxidation in phagosomes of human neutrophils: correlation with expression of flavocyto-chrome b. J. Leukoc. Biol. 57, 415-421.
89. Barden, A, Ritchie, J., Walters, B., Michael, C, Rivera, J., Mori, T., Croft, K, Beilin, L. (2001) Study of plasma factors associated with neutrophil activation and lipid peroxidation in preeclampsia. Hypertension 38, 803-808.
90. Leik, C. E., Walsh, S. W. (2004) Neutrophils infiltrate resistance-sized vessels of subcutaneous fat in women with preeclampsia. Hypertension 44, 72-77.
91. Gupta, A., Hasler, P., Holzgreve, W., Gebhardt, S., Hahn, S. (2005) Induction of neutrophil extracellular DNA lattices by placental micropar-ticles and IL-8 and their presence in preeclampsia. Hum. Immunol. 66, 1146-1154.
92. Fuchs, T. A., Abed, U., Goosmann, C, Hurwitz, R., Schulze, I., Wahn, V., Weinrauch, Y., Brinkmann, V., Zychlinsky, A. (2007) Novel cell death program leads to neutrophil extracellular traps. J. Cell Biol. 176, 231-241.
93. Kaplan, M. J., Radic, M. (2012) Neutrophil extracellular traps: double-edged swords of innate immunity. J. Immunol. 189, 2689-2695.
94. Gupta, A, Hasler, P., Holzgreve, W., Hahn, S. (2007) Neutrophil NETs: a novel contributor to preeclampsia-associated placental hypoxia? Semin. Immunopathol. 29, 163-167.
95. Saffarzadeh, M., Juenemann, C, Queisser, M. A., Lochnit, G., Barreto, G., Galuska, S. P., Lohmeyer, J., Preissner, K. T. (2012) Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS ONE 7, e32366.
96. Remijsen, Q., Kuijpers, T. W., Wirawan, E., Lippens, S., Vandenabeele, P., Vanden Berghe, T. (2011) Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality. Cell Death Differ. 18, 581-588.
97. Gandley, R E., Rohland, J., Zhou, Y., Shibata, E., Harger, G. F., Raja-kumar, A, Kagan, V. E., Markovic, N., Hubel, C. A. (2008) Increased myeloperoxidase in the placenta and circulation of women with preeclampsia. Hypertension 52, 387-393.
98. Guleria, I., Sayegh, M. H. (2007) Maternal acceptance of the fetus: true human tolerance. J. Immunol. 178, 3345-3351.
99. Lash, G. E., Otun, H. A, Innes, B. A, Kirkley, M., De Oliveira, L., Searle, RF., Robson, S. C, Bulmer, J. N. (2006) Interferon-7 inhibits extravillous trophoblast cell invasion by a mechanism that involves both changes in apoptosis and protease levels. FASEBJ. 20, 2512-2518.
100. Molvarec, A., Ito, M., Shima, T., Yoneda, S., Toldi, G., Stenczer, B., Vasarhelyi, B., Rigo Jr., J., Saito, S. (2010) Decreased proportion of peripheral blood vascular endothelial growth factor-expressing T and natural killer cells in preeclampsia. Am. J. Obstet. Gynecol. 203, 567.e1-567.e8.
101. Sivori, S., Falco, M., Chiesa, M. D., Carlomagno, S., Vitale, M., Moretta, L., Moretta, A. (2004) CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc. Natl. Acad. Sci. USA 101, 10116-10121.
102. Hedlund, M., Stenqvist, A-C, Nagaeva, O., Kjellberg, L., Wulff, M., Baranov, V., Mincheva-Nilsson, L. (2009) Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function. J. Immunol. 183, 340-351.
103. Jurewicz, M., McDermott, D. H., Sechler, J. M., Tinckam, K, Takakura, A, Carpenter, C. B., Milford, E., Abdi, R (2007) Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation. J. Am. Soc. Nephrol. 18, 1093-1102.
104. Herse, F., Dechend, R, Harsem, N. K, Wallukat, G., Janke, J., Qadri, F., Hering, L., Muller, D. N., Luft, F. C, Staff, A. C. (2007) Dysregula-tion of the circulating and tissue-based renin-angiotensin system in preeclampsia. Hypertension 49, 604-611.
105. Blois, S. M., Kammerer, U., Alba Soto, C, Tometten, M. C, Shaikly, V., Barrientos, G., Jurd, R, Rukavina, D., Thomson, A. W., Klapp, B. F., Fernández, N., Arck, P. C. (2007) Dendritic cells: key to fetal tolerance? Biol. Reprod. 77, 590-598.
106. Steinman, R M., Hemmi, H. (2006) Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 311, 17-58.
107. Blois, S., Tometten, M., Kandil, J., Hagen, E., Klapp, B. F., Margni, R A, Arck, P. C. (2005) Intercellular adhesion molecule-1/LFA-1 cross talk is a proximate mediator capable of disrupting immune integration and tolerance mechanism at the feto-maternal interface in murine pregnancies.J. Immunol. 174, 1820-1829.
108. Hsu, P., Santner-Nanan, B., Dahlstrom, J. E., Fadia, M., Chandra, A., Peek, M., Nanan, R (2012) Altered decidual DC-SIGN+ antigen-presenting cells and impaired regulatory T-cell induction in preeclampsia. Am. J. Pathol. 181, 2149-2160.
109. Kludka-Sternik, M., Serafin, A, Darmochwal-Kolarz, D., Radej, S., Ro-linski, J., Leszczynska-Gorzelak, B., Oleszczuk, J. (2010) The expression of B7-H1 and B7-H4 molecules on immature myeloid and lymphoid dendritic cells in cord blood of healthy neonates. Folia Histochem. Cyto-biol. 48, 658-662.
110. Darmochwal-Kolarz, D., Rolinski, J., Tabarkiewicz, J., Leszczynska-Gorzelak, B., Buczkowski, J., Wojas, K, Oleszczuk, J. (2003) Myeloid and lymphoid dendritic cells in normal pregnancy and pre-eclampsia. Clin. Exp. Immunol. 132, 339-344.
111. Leslie, D. S., Vincent, M. S., Spada, F. M., Das, H., Sugita, M., Morita, C. T., Brenner, M. B. (2002) CD1-mediated y/8 T cell maturation of dendritic cells. J. Exp. Med. 196, 1575-1584.
112. Banchereau, J., Briere, F., Caux, C, Davoust, J., Lebecque, S., Liu, Y J., Pulendran, B., Palucka, K (2000) Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811.
113. Schroder, W. A, Le, T. T., Major, L., Street, S., Gardner, J., Lambley, E., Markey, K, MacDonald, K. P., Fish, R J., Thomas, R, Suhrbier, A (2010) A physiological function of inflammation-associated SerpinB2 is regulation of adaptive immunity. J. Immunol. 184, 2663-2670.
114. Ohkuchi, A, Minakami, H., Aoya, T., Haga, T., Kimura, H., Suzuki, M., Sato, I. (2001) Expansion of the fraction ofTh1 cells in women with preeclampsia: inverse correlation between the percentage of Th1 cells and the plasma level of PAI-2. Am. J. Reprod. Immunol. 46, 252-259.
115. Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F., Lanzavecchia, A (2001) Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 31, 3388-3393.
116. Panda, B., Panda, A, Ueda, I., Abrahams, V. M., Norwitz, E. R, Stanic, A. K, Young, B. C, Ecker, J. L., Altfeld, M., Shaw, A. C, Rueda, B. R (2012) Dendritic cells in the circulation of women with preeclampsia demonstrate a pro-inflammatory bias secondary to dysregulation of TLR receptors. J. Reprod. Immunol. 94, 210-215.
117. Berghöfer, B., Haley, G., Frommer, T., Bein, G., Hackstein, H. (2007) Natural and synthetic TLR7 ligands inhibit CpG-A-and CpG-C-oligode-oxynucleotide-induced IFN-a production. J. Immunol. 178, 4072-4079.
118. Rutella, S., Danese, S., Leone, G. (2006) Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 108, 1435-1440.
119. Muthuswamy, R, Urban, J., Lee, J. J., Reinhart, T. A, Bartlett, D., Ka-linski, P. (2008) Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation. Cancer Res. 68, 5972-5978.
120. Verlohren, S., Muller, D. N., Luft, F. C, Dechend, R (2009) Immunology in hypertension, preeclampsia, and target-organ damage. Hypertension 54, 439-443.
121. Banerjee, S., Smallwood, A., Moorhead, J., Chambers, A. E., Papa-georghiou, A, Campbell, S., Nicolaides, K (2005) Placental expression of interferon-7 (IFN-7) and its receptor IFN-7 R2 fail to switch from early hypoxic to late normotensive development in preeclampsia. J. Clin. Endocrinol. Metab. 90, 944-952.
122. Arriaga-Pizano, L., Jimenez-Zamudio, L., Vadillo-Ortega, F., Martinez-Flores, A, Herrerias-Canedo, T., Hernandez-Guerrero, C. (2005) The predominant Th1 cytokine profile in maternal plasma of preeclamptic women is not reflected in the choriodecidual and fetal compartments. J. Soc. Gynecol. Invest. 12, 335-342.
123. Murphy, S. P., Tayade, C, Ashkar, A. A, Hatta, K, Zhang, J., Croy, B.A. (2009) Interferon 7 in successful pregnancies. Biol. Reprod. 80, 848-859.
124. Moreau, P., Adrian-Cabestre, F., Menier, C, Guiard, V., Gourand, L., Dausset, J., Carosella, E. D., Paul, P. (1999) IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int. Immunol. 11, 803-811.
125. Steinborn, A, Schmitt, E., Kisielewicz, A, Rechenberg, S., Seissler, N., Mahnke, K, Schaier, M., Zeier, M., Sohn, C. (2012) Pregnancy-associated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs. Clin. Exp. Immunol. 167, 84-98.
126. Paeschke, S., Chen, F., Horn, N., Fotopoulou, C, Zambon-Bertoja, A, Sollwedel, A, Zenclussen, M. L., Casalis, P. A, Dudenhausen, J. W., Volk, H-D., Zenclussen, A. C. (2005) Pre-eclampsia is not associated with changes in the levels of regulatory T cells in peripheral blood. Am. J. Reprod. Immunol. 54, 384-389.
127. Steinborn, A, Haensch, G., Mahnke, K, Schmitt, E., Toermer, A, Meuer, S., Sohn, C. (2008) Distinct subsets of regulatory T cells during pregnancy: is the imbalance of these subsets involved in the pathogenesis of preeclampsia? Clin. Immunol. 129, 401-412.
128. Toldi, G., Svec, P., Vasarhelyi, B., Meszaros, G., Rigo, J., Tulassay, T., Treszl, A. (2008) Decreased number of FoxP3+ regulatory T cells in preeclampsia. Acta Obstet. Gynecol. Scand. 87, 1229-1233.
129. Darmochwal-Kolarz, D., Kludka-Sternik, M., Tabarkiewicz, J., Kolarz, B., Rolinski, J., Leszczynska-Gorzelak, B., Oleszczuk, J. (2012) The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J. Reprod. Immunol. 93, 75-81.
130. Saito, S., Nakashima, A, Ito, M., Shima, T. (2011) Clinical implication of recent advances in our understanding of IL-17 and reproductive immunology. Exp. Rev. Clin. Immunol. 7, 649-657.
131. Santner-Nanan, B., Peek, M. J., Khanam, R, Richarts, L., Zhu, E., Faze-kas de St Groth, B., Nanan, R. (2009) Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J. Immunol. 183, 7023-7030.
132. Jianjun, Z., Yali, H., Zhiqun, W., Mingming, Z., Xia, Z. (2010) Imbalance of T-cell transcription factors contributes to the Th1 type immunity predominant in pre-eclampsia. Am. J. Reprod. Immunol. 63, 38-45.
133. Saito, S. (2010) Th17 cells and regulatory T cells: new light on pathophysiology of preeclampsia. Immunol. Cell Biol. 88, 615-617.
134. Toldi, G., Rigo Jr., J., Stenczer, B., Vasarhelyi, B., Molvarec, A. (2011) Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia. Am. J. Reprod. Immunol. 66, 223-229.
135. Jensen, F., Wallukat, G., Herse, F., Budner, O., El-Mousleh, T., Costa, S-D., Dechend, R., Zenclussen, A. C. (2012) CD19 + CD5+ cells as indicators of preeclampsia. Hypertension 59, 861-868.
136. Berland, R., Wortis, H. H. (2002) Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20, 253-300.
137. Sato, S., Ono, N., Steeber, D., Pisetsky, D., Tedder, T. (1996) CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J. Immunol. 157, 4371-4378.
138. Vinuesa, C. G., Sanz, I., Cook, M. C. (2009) Dysregulation of germinal centres in autoimmune disease. Nat. Rev. Immunol. 9, 845-857.
139. Ebeling, S. B., Schutte, M. E., Logtenberg, T. (1993) The majority of human tonsillar CD5+ B cells express somatically mutated V k 4 genes. Eur. J. Immunol. 23, 1405-1408.
140. Casali, P., Burastero, S., Nakamura, M., Inghirami, G., Notkins, A. (1987) Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. Science 236, 77-81.
141. Wallukat, G., Homuth, V., Fischer, T., Lindschau, C, Horstkamp, B., Jüpner, A, Baur, E., Nissen, E., Vetter, K, Neichel, D., Dudenhausen, J. W., Haller, H., Luft, F. C. (1999) Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J. Clin. Invest. 103, 945-952.
142. Siddiqui, A. H., Irani, R A, Blackwell, S. C, Ramin, S. M., Kellems, R E., Xia, Y. (2010) Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity. Hypertension 55, 386-393.
143. Dechend, R, Homuth, V., Wallukat, G., Muller, D. N., Krause, M., Dudenhausen, J., Haller, H., Luft, F. C. (2006) Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia. J. Soc. Gynecol. Investig. 13, 79-86.
144. Zhou, C. C., Irani, R. A., Dai, Y., Blackwell, S. C., Hicks, M. J., Ramin, S. M., Kellems, R. E., Xia, Y. (2011) Autoantibody-mediated IL-6-depen-dent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia. J. Immunol. 186, 6024-6034.
145. Yang, X., Wang, F., Chang, H., Zhang, S., Yang, L., Wang, X., Cheng, X., Zhang, M., Ma, X. L., Liu, H. (2008) Autoantibody against AT1 receptor from preeclamptic patients induces vasocon-striction through angiotensin receptor activation. J. Hypertens. 26, 1629-1635.
146. LaMarca, B., Wallace, K., Herse, F., Wallukat, G., Martin, J. N., Weimer, A., Dechend, R. (2011) Hypertension in response to placental ischemia during pregnancy. Hypertension 57, 865-871.
147. Irani, R. A., Zhang, Y., Blackwell, S. C., Zhou, C. C., Ramin, S. M., Kel-lems, R. E., Xia, Y. (2009) The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia. J. Exp. Med. 206, 2809-2822.
148. Hubel, C. A., Wallukat, G., Wolf, M., Herse, F., Rajakumar, A., Roberts, J. M., Markovic, N., Thadhani, R., Luft, F. C., Dechend, R. (2007) Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension 49, 612-617.
149. Ma, G., Li, Y., Zhang, J., Liu, H., Hou, D., Zhu, L., Zhang, Z., Zhang, L. (2013) Association between the presence of autoantibodies against adrenoreceptors and severe pre-eclampsia: a pilot study. PLoS ONE 8, e57983.